Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says
Summary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
Summary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…
Summary : The DTAB has approved a list of OTC drugs which includes medicines like antifungal infections, analgesics (pain killers), cough syrups,…
Summary : Vigabatrin is used to treat babies, one month to two years old with infantile spasms. Zydus has received final approval…
Summary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
Synopsis : Natco Pharma Limited and Biophore India Pharmaceuticals have received the license from the Medicines Patent Pool (MPP), Switzerland, to manufacture and…
Summary : The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg…
9 – 10 February 2022, Virtual Conference: Online Access Only. 3D Cell Culture is gaining momentum in the pharmaceutical industry on account…
Summary : If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at…
Summary : Cancer Research UK announces clinical trial for most common type of lung cancer Cancer Research UK have announced that the…